期刊
HEALTH AFFAIRS
卷 35, 期 6, 页码 974-982出版社
PROJECT HOPE
DOI: 10.1377/hlthaff.2016.0064
关键词
-
资金
- Agency for Healthcare Research and Quality (AHRQ) [U19HS021112, R18HS019937, R18HS023258]
- Patient-Centered Outcomes Research Institute (PCORI) [IHS-140923194]
- AHRQ
- Centers for Medicare and Medicaid Services [U18HS020503]
The rapid growth of antipsychotic medication use among publicly insured children in the early and mid-2000s spurred new state efforts to monitor and improve prescription behavior. A starting point for many oversight initiatives was the foster care system, where most of the children are insured publicly through Medicaid. To understand the context and the effects of these initiatives, we analyzed patterns and trends in antipsychotic treatment of Medicaid-insured children in foster care and those in Medicaid but not in foster care. We found that the trend of rapidly increasing use of antipsychotics appears to have ceased since 2008. Children in foster care treated with antipsychotic medications are now more likely than other Medicaid-insured children to receive psychosocial interventions and metabolic monitoring for the side effects of the medications. However, challenges persist in increasing safety monitoring and access to psychosocial treatment. Development of specialized managed care plans for children in foster care represents a promising policy opportunity. New national quality measures for safe and judicious antipsychotic medication use are also now available to guide improvement. Oversight policies developed for foster care appear to have potential for adaptation to the broader population of Medicaid-covered children.
作者
我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。
推荐
暂无数据